流行病学研究关于耐美西林黄金葡萄球菌肠炎的病例定义
Yusuke Yagi1,2, Akito Doke1,3, Saya Iwame1,3
1Department of Infection Prevention and Control, Kochi Medical School Hospital, Nankoku, Kochi, Japan.
Infection and drug resistance
|June 10, 2024
概括
通过识别关键风险因素,可以改善对甲素耐药黄金葡萄球菌 (MRSA) 肠炎的诊断. 升高的白细胞计数,高的MRSA便培养计数和最近使用梅罗的重要指标.
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 临床医学 临床医学
背景情况:
- 甲基西林耐药黄金葡萄球菌 (MRSA) 肠炎是由抗生素使用后肠道MRSA生长异常引起的.
- 目前对MRSA肠炎的诊断标准缺乏明确性,需要进行流行病学研究.
- 从临床上来说,区分MRSA肠炎与无症状MRSA携带是非常重要的.
研究的目的:
- 通过流行病学调查来定义MRSA肠炎的诊断标准.
- 为了确定与MRSA肠炎的发展相关的风险因素.
主要方法:
- 分析了一组阳性MRSA便培养的患者队列.
- MRSA肠炎被定义为对万科米辛的反应,严重的腹 (布里斯托尔便量 ≥ 5) 和高便频率 (≥ 3/天).
- 多变量后勤回归确定了MRSA肠炎的风险因素.
主要成果:
- 18名患者 (25.4%) 被归类为MRSA肠炎 (A组),53名 (74.6%) 被归类为MRSA携带者 (B组).
- 患MRSA肠炎的危险因素包括白细胞数量升高 (> 10000/μL),高MRSA便培养数量 (≥ 2+),以及最近服用梅罗 (在1个月内).
- 这些因素的赔率比率从5.50到8.91.9不等.
结论:
- 关于MRSA肠炎的拟议病例定义可以作为有价值的诊断标准.
- 识别这些风险因素可以帮助准确诊断MRSA肠炎.
更多相关视频
相关概念视频
Investigation of Disease Outbreaks
Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


